Do Pharmaceutical Prices Respond to Insurance?, Issue 7865
National Bureau of Economic Research, 2000 - Pharmaceutical services insurance - 22 pages
Despite the importance of patient insurance in the market for prescription pharmaceuticals, little is known about the impact of insurance on the pricing behavior of pharmaceutical firms. This paper examines the link between insurance and pricing using a unique policy experiment from Germany. Starting in 1989, a maximum reimbursement for a given medicine replaced a flat prescription fee. This change in insurance reimbursement exposes the patient to the price of a prescribed product. Using a product level panel dataset covering several therapeutic categories before and after the change in insurance reimbursement, I find that producers significantly decrease prices after the change in insurance. Price declines are most pronounced for brand name products. Moreover, branded products that face more generic competitors reduce prices more.
What people are saying - Write a review
We haven't found any reviews in the usual places.
active ingredient group affect prices affects the pricing analysis antidiabetics and antiulcerants average daily dose behavior of pharmaceutical brand name products changes in insurance Creative Destruction decline dependent variable dose and measured drugs Economics Effect of I11ura1ce effect of insurance estimated using product Germany given active ingredient glibenclamide H2 antagonists Health Insurance Herfindahl index impact of insurance implementation imposition of reference IMS Health indicate significance indicator variable post insurance and pricing insurance change insurance reimbursement intertemporal variation maximum reimbursement measured in 1990 Medicaid moral hazard name and zero Nina Pavcnik oral antidiabetics package patient insurance pharmaceutical firms pharmaceutical pricing pharmaceutical products physicians post indicator prescribing prescription fee prescription pharmaceuticals pric1 price of brands prices are expressed pricing behavior product prices product random effects reform regressions are estimated regressors reimbursement level retail pharmacies Standard errors Table therapeutic group unobserved variable is log www.nber.org yes yes yes zero otherwise